Bill > HB13

This bill, titled "Prescription drugs; authorize to be imported into the State of Mississippi," aims to allow for the importation of prescription drugs into Mississippi to potentially lower costs for the state. It defines key terms like "eligible importer" (which can be a wholesale distributor, licensed pharmacist, or pharmacy) and "eligible exporter" (an international prescription drug wholesale distributor, a nonresident prescription drug manufacturer, or an international export pharmacy). The bill permits an eligible importer to bring prescription drugs from an eligible exporter into Mississippi, provided the drugs meet the United States Food and Drug Administration's (FDA) standards for safety and effectiveness, are not misbranded or adulterated, and do not violate U.S. patent laws. The bill also makes a technical change to Section 41-29-117 of the Mississippi Code of 1972, which lists controlled substances, by adding kratom (mitragynine and 7-hydroxymytragynine) to Schedule III, indicating it is a controlled substance. This legislation is set to take effect on July 1, 2026.

Health and Social Services

https://billstatus.ls.state.ms.us/2026/pdf/history/HB/HB0013.xml